The innovative technology of “Bio 3D Printing” by Cyfuse was created through a deft fusion of the latest insights and technologies in the disparate fields of biology and engineering.
Cyfuse is working toward the creation of “hope” for novel therapies using “cells” by leveraging this one-of-a-kind platform technology in various ways in research and clinical settings to contribute to dramatic progress in the field of regenerative and cellular medicine.
Against the backdrop of the increasingly expanding practical application and industrialization of regenerative medicine and cellular therapy, Cyfuse has been hard at work primarily on the development of regenerative medical products in the field of regenerative medicine and cellular therapy to contribute toward the creation of novel cellular products, as well as the development of various technologies using state-of-the-art devices equipped with our own unique platform technology.
The goal of Cyfuse is to enable practical applications of “3D cellular products” based on Bio 3D Printing technology in order to deliver new, previously unavailable treatment options to patients.
Practical applications of such 3D cellular products may lead to revolutionary therapeutic approaches for regenerating lost organs and functions, address medical needs unmet by conventional surgery and therapies, and contribute substantially to medical progress.
The design of the Cyfuse corporate logo, composed of three spheres, is a visualization of the Cyfuse platform technology for fabricating steric tissues and organs through the power of cells alone.
The Three Spheres
The logo embodies the aspiration of Cyfuse to contribute toward medical progress using innovative technology for better health of more people.
Owing to its dedication to serving the community using the power of innovative technology, Cyfuse is contributing to the development of new treatments.